Archive

Author Archive

RegMed Daily Dialogue, Mid-Day, 9/14/11, pessimism deepens as confidence falls further

September 14th, 2011 No comments

            The 6 W’s: Who, what, where, when, why and what of it… Read more…

Categories: RegMed Daily Dialogue

The Daily Look, Starting the Day, 9/14/11

September 14th, 2011 No comments

                Good morning!  Read more…

The Daily Look, EOD, Closing Bell, 9/13/11

September 13th, 2011 No comments

          End of Day, Cause and Effect, so what’s causing the rise or bounces? Read more…

RegMed Daily Dialogue, Mid-Day, 9/13/11, lack of conviction emanates from the buy side

September 13th, 2011 Comments off

             The 6 W’s: Who, what, where, when, why and what of it… Read more…

Categories: RegMed Daily Dialogue

ThermoGenesis (KOOL) Reports Q4/11 and FY11 Results

September 13th, 2011 No comments

     KOOL reported a Q4/11 net loss of $1.2M or $0.07 per share Read more…

The Daily Look, Starting the Day, 9/13/11

September 13th, 2011 No comments

Good morning!  Here’s what you might need to know to start the day… to understand the gyrations in the RegMed universe’s market!

Read more…

The Daily Look, EOD, Closing Bell, 9/12/11

September 12th, 2011 No comments

       End of Day, Cause and Effect, so what’s causing the rise or bounces?  Read more…

RegMed Daily Dialogue, Mid-Day, 9/12/11, catching a falling knife, the ripple effect

September 12th, 2011 No comments

        The 6 W’s: Who, what, where, when, why and what of it… Read more…

Categories: RegMed Daily Dialogue

Alchemia (ASX: ACL) announces Initiation of P2 trial in Small Cell Lung Cancer

September 12th, 2011 No comments

ASX: ACL is about to initiate recruitment to a 390 patient pivotal P3 study of HA-Irinotecan in metastatic colorectal (bowel) cancer. Read more…

The Daily Look, Starting the Day, 9/12/11

September 12th, 2011 No comments

Starting the day followed by early news and Rodman & Renshaw  conference presentations.  Read more…

Categories: The Daily Look